Share-Based Compensation (Tables)

12 Months Ended

Dec. 31, 2024

Share-Based Payment Arrangement [Abstract]

Schedule of Common Stock Reserved for Future Issuance

The Company has the following shares of common stock reserved for future issuance, on an as-if converted basis:

	As of December 31,
	2024	2023
Warrants to purchase common stock	3,048,679	3,282,652
Outstanding Private Placement Warrants	7,386,667	7,386,667
Stock options issued and outstanding under 2018 Plan	7,032,106	7,813,366
Shares available for grant under 2022 Plan(1)	827,067	2,052,669
RSUs issued and outstanding under 2022 Plan	12,602,962	17,434,138
Shares available for grant under 2022 ESPP	7,566,607	5,797,609
Total shares of common stock reserved	38,464,088	43,767,101

(1) To the extent outstanding options granted under the 2018 Plan are cancelled, forfeited, or otherwise terminated without being exercised and would have been returned to the share reserve under the 2018 Plan following the closing date of the Merger, the number of shares of common stock underlying such awards will be available for future awards under the 2022 Plan.

Schedule of Share-Based Compensation Expense

Stock compensation for the periods indicated below are as follows (in thousands):

	Year ended December 31,
	2024		2023
RSUs	$	27,232	$	29,573
Stock options	3,257		4,761
Total share-based compensation	$	30,489	$	34,334

Schedule of Stock Option Activity

Stock option activity during the years ended December 31, 2024 and 2023, consisted of the following (in thousands, except for share and per share data):

	Stock options	Weighted-Average Exercise Price	Weighted-Average Life (Years)	Aggregate Intrinsic Value
Balance as of December 31, 2022	12,853,072	$2.39	7.0	$	7,055
Exercised	(1,268,982)	0.64
Cancelled/Forfeited/Expired(1)	(3,770,724)	3.64
Balance as of December 31, 2023	7,813,366	$2.06	6.0	$	14,942
Exercised	(653,386)	0.83
Cancelled/Forfeited/Expired	(127,874)	3.83
Balance as of December 31, 2024	7,032,106	$2.15	5.2	$	1,571
Vested and exercisable as of December 31, 2024	6,824,824	$2.10	5.2	$	1,565

(1) Effective June 15, 2023, the Company cancelled the CEO Option (as defined below), which was granted under the 2018 Plan. As a result of such cancellation, the 3,122,931 shares of common stock underlying the CEO Option became available for future awards under the 2022 Plan.

Schedule of RSU Activity

RSU activity during the years ended December 31, 2024 and 2023 was as follows:

	Total RSUs	Time-based	Performance-based	Market-based	Weighted-Average Grant Date Fair Value Per Share
Unvested as of December 31, 2022	10,578,313	9,171,289	—	1,407,025	$	10.04
Granted	12,199,830	8,055,250	1,805,550	2,339,030	1.64
Vested	(3,552,392)	(3,083,382)	—	(469,010)	10.09
Forfeited	(1,791,613)	(1,791,613)	—	—	8.72
Unvested as of December 31, 2023	17,434,138	12,351,544	1,805,550	3,277,044	$	4.30
Granted	8,686,496	7,218,327	1,468,169	—	1.89
Vested(1)	(11,501,795)	(9,762,974)	(1,269,814)	(469,007)	3.50
Forfeited	(2,015,877)	(1,712,997)	(302,880)	—	5.04
Unvested as of December 31, 2024	12,602,962	8,093,900	1,701,025	2,808,037	$	3.26

(1) Common stock has not been issued in connection with 256,014 vested RSUs because such RSUs were unsettled as of December 31, 2024.